Covered recipient · General Payments record
PATRICK GRIFFITH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,325.85
- Reported across 186 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $422.82 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $252.23 | 17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $88.99 | 5 |
| Esperion Therapeutics, Inc. | $30.07 | 2 |
| PFIZER INC. | $24.62 | 1 |
| TOLMAR, INC. | $13.53 | 1 |
| Lilly USA, LLC | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.70 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839882 | CMS |
| ABBVIE INC. | $12.22 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839884 | CMS |
| ABBVIE INC. | $10.33 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839886 | CMS |
| ABBVIE INC. | $20.22 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839888 | CMS |
| ABBVIE INC. | $22.60 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839890 | CMS |
| ABBVIE INC. | $12.27 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839892 | CMS |
| ABBVIE INC. | $13.96 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839894 | CMS |
| ABBVIE INC. | $24.41 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839896 | CMS |
| ABBVIE INC. | $15.39 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839898 | CMS |
| ABBVIE INC. | $10.20 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839900 | CMS |
| ABBVIE INC. | $14.80 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839902 | CMS |
| ABBVIE INC. | $20.19 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839904 | CMS |
| ABBVIE INC. | $15.40 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839906 | CMS |
| ABBVIE INC. | $10.94 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839908 | CMS |
| ABBVIE INC. | $13.11 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839910 | CMS |
| ABBVIE INC. | $14.84 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839912 | CMS |
| ABBVIE INC. | $13.65 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103839914 | CMS |
| Esperion Therapeutics, Inc. | $16.64 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129436870 | CMS |
| Esperion Therapeutics, Inc. | $13.43 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129436872 | CMS |
| Lilly USA, LLC | $13.38 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135280886 | CMS |
| PFIZER INC. | $24.62 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131466357 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.81 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563493 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.16 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563497 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.08 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563501 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.54 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563504 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.40 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137563508 | CMS |
| Tolmar, Inc. | $13.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138714914 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.